{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T20:31:59Z","timestamp":1779309119697,"version":"3.51.4"},"reference-count":147,"publisher":"Springer Science and Business Media LLC","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Appl Microbiol Biotechnol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1007\/s00253-012-4484-3","type":"journal-article","created":{"date-parts":[[2012,10,17]],"date-time":"2012-10-17T15:43:36Z","timestamp":1350488616000},"page":"1157-1174","source":"Crossref","is-referenced-by-count":106,"title":["Peptidoglycan hydrolases-potential weapons against Staphylococcus aureus"],"prefix":"10.1007","volume":"96","author":[{"given":"Piotr","family":"Szweda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Schielmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"Kotlowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grzegorz","family":"Gorczyca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magdalena","family":"Zalewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Slawomir","family":"Milewski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,18]]},"reference":[{"key":"4484_CR1","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ijantimicag.2011.02.009","volume":"37","author":"A Aguinaga","year":"2011","unstructured":"Aguinaga A, Franc\u00e9s ML, Del Pozo JL, Alonso M, Serrera A, Lasa I, Leiva J (2011) Lysostaphin and clarithromycin: a promising combination for the eradication of Staphylococcus aureus biofilms. Int J Antimicrob Agents 37:585\u2013587","journal-title":"Int J Antimicrob Agents"},{"key":"4484_CR2","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1159\/000141513","volume":"17","author":"M Aligholi","year":"2008","unstructured":"Aligholi M, Emaneini M, Jabalameli F, Shahsavan S, Dabiri H, Sedaght H (2008) Emergence of high-level vancomycin-resistant Staphylococcus aureus in the Imam Khomeini Hospital in Tehran. Med Princ Pract 17:432\u2013434","journal-title":"Med Princ Pract"},{"key":"4484_CR3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1093\/jac\/44.1.43","volume":"44","author":"B Amorena","year":"1999","unstructured":"Amorena B, Gracia E, Monzon M, Leiva J, Oteiza C, Perez JL, Alabart JL, Hernandez-Yago J (1999) Antibiotic susceptibility assay for Staphylococcus aureus in biofilms developed in vitro. J Antimicrob Chemother 44:43\u201355","journal-title":"J Antimicrob Chemother"},{"key":"4484_CR4","doi-asserted-by":"crossref","first-page":"7573","DOI":"10.1128\/JB.01048-07","volume":"189","author":"A Antignac","year":"2007","unstructured":"Antignac A, Sieradzki K, Tomasz A (2007) Perturbation of cell wall synthesis suppresses autolysis in Staphylococcus aureus: evidence for coregulation of cell wall synthetic and hydrolytic enzymes. J Bacteriol 189:7573\u20137580","journal-title":"J Bacteriol"},{"key":"4484_CR5","doi-asserted-by":"crossref","first-page":"18991","DOI":"10.1073\/pnas.1004304107","volume":"107","author":"ML Atilano","year":"2010","unstructured":"Atilano ML, Pereira PM, Yates J, Reed P, Veiga H, Pinho MG, Filipe SR (2010) Teichoic acids are temporal and spatial regulators of peptidoglycan cross-linking in Staphylococcus aureus. Proc Natl Acad Sci U S A 107:18991\u201318996","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"suppl","key":"4484_CR6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/clinids\/24.Supplement_1.S74","volume":"24","author":"GAJ Ayliffe","year":"1997","unstructured":"Ayliffe GAJ (1997) The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 24(suppl):74\u201379","journal-title":"Clin Infect Dis"},{"key":"4484_CR7","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1128\/AAC.48.5.1681-1687.2004","volume":"48","author":"IS Barequet","year":"2004","unstructured":"Barequet IS, Ben Simon GJ, Safrin M, Ohman DE, Kessler E (2004) Pseudomonas aeruginosa LasA protease in treatment of experimental staphylococcal keratitis. Antimicrob Agents Chemother 48:1681\u20131687","journal-title":"Antimicrob Agents Chemother"},{"key":"4484_CR8","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1007\/s00417-009-1061-2","volume":"247","author":"IS Barequet","year":"2009","unstructured":"Barequet IS, Habot-Wilner Z, Mann O, Safrin M, Ohman DE, Kessler E, Rosner M (2009) Evaluation of Pseudomonas aeruginosa staphylolysin (LasA protease) in the treatment of methicillin-resistant Staphylococcus aureus endophthalmitis in a rat model. Graefes Arch Clin Exp Ophthalmol 247:913\u2013917","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4484_CR9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00417-011-1822-6","volume":"250","author":"IS Barequet","year":"2012","unstructured":"Barequet IS, Bourla N, Pessach YN, Safrin M, Yankovich D, Ohman DE, Rosner M, Kessler E (2012) Staphylolysin is an effective therapeutic agent for Staphylococcus aureus experimental keratitis. Graefes Arch Clin Exp Ophthalmol 250:223\u2013229","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4484_CR10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1574-6968.2008.01308.x","volume":"287","author":"SC Becker","year":"2008","unstructured":"Becker SC, Foste-Frey J, Donovan DM (2008) The phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA. FEMS Microbiol Lett 287:185\u2013191","journal-title":"FEMS Microbiol Lett"},{"key":"4484_CR11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1574-6968.2009.01541.x","volume":"294","author":"SC Becker","year":"2009","unstructured":"Becker SC, Dong S, Baker JR, Foster-Frey J, Pritchard DG, Donovan DM (2009) LysK CHAP endopeptidase domain is required for lysis of live staphylococcal cells. FEMS Microbiol Lett 294:52\u201360","journal-title":"FEMS Microbiol Lett"},{"key":"4484_CR12","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.jss.2011.04.014","volume":"171","author":"I Belyansky","year":"2011","unstructured":"Belyansky I, Tsirline VB, Martin TR, Klima DA, Heath J, Lincourt AE, Satishkumar R, Vertegel A, Heniford BT (2011) The addition of lysostaphin dramatically improves survival, protects porcine biomesh from infection, and improves graft tensile shear strength. J Surg Res 171:409\u2013415","journal-title":"J Surg Res"},{"key":"4484_CR13","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1365-2958.2004.04446.x","volume":"55","author":"A Bera","year":"2005","unstructured":"Bera A, Herbert S, Jakob A, Vollmer W, Gotz F (2005) Why are pathogenic staphylococci so lysozyme resistant? The peptidoglycan O-acetyltransferase OatA is the major determinant for lysozyme resistance of Staphylococcus aureus. Mol Microbiol 55:778\u2013787","journal-title":"Mol Microbiol"},{"key":"4484_CR14","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.1128\/IAI.00301-06","volume":"74","author":"A Bera","year":"2006","unstructured":"Bera A, Biswas R, Herbert S, G\u00f6tz F (2006) The presence of peptidoglycan O-acetyltransferase in various staphylococcal species correlates with lysozyme resistance and pathogenicity. Infect Immun 74:4598\u20134604","journal-title":"Infect Immun"},{"key":"4484_CR15","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1128\/JB.01221-06","volume":"189","author":"A Bera","year":"2007","unstructured":"Bera A, Biswas R, Herbert S, Kulauzovic E, Weidenmaier C, Peschel A, G\u00f6tz F (2007) Influence of wall teichoic acid on lysozyme resistance in Staphylococcus aureus. J Bacteriol 189:280\u2013283","journal-title":"J Bacteriol"},{"key":"4484_CR16","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/j.1574-6968.2006.00281.x","volume":"259","author":"R Biswas","year":"2006","unstructured":"Biswas R, Voggu L, Simon UK, Hentschel P, Thumm G, G\u00f6tz F (2006) Activity of the major staphylococcal autolysin Atl. FEMS Microbiol Lett 259:260\u2013268","journal-title":"FEMS Microbiol Lett"},{"key":"4484_CR17","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1136\/bmj.1.5388.983","volume":"1","author":"J Borowski","year":"1964","unstructured":"Borowski J, Kamienska K, Rutecki I (1964) Methicillin-resistant staphylococci (letter). Br Med J 1:983","journal-title":"Br Med J"},{"key":"4484_CR18","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1177\/153537020623100402","volume":"231","author":"J Borysowski","year":"2006","unstructured":"Borysowski J, Weber-Dabrowska B, Gorski A (2006) Bacteriophage endolysins as a novel class of antibacterial agent. Exp Biol Med 231:366\u2013377","journal-title":"Exp Biol Med"},{"key":"4484_CR19","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/jac\/48.5.617","volume":"48","author":"S Boyle-Vavra","year":"2001","unstructured":"Boyle-Vavra S, Carey RB, Daum RS (2001) Development of vancomycin and lysostaphin resistance in a methicillin-resistant Staphylococcus aureus isolate. J Antimicrob Chemother 48:617\u2013625","journal-title":"J Antimicrob Chemother"},{"key":"4484_CR20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/0923-2508(89)90046-6","volume":"140","author":"N Brito","year":"1989","unstructured":"Brito N, Falcon MA, Carnicero A, Gutierrez-Navarro AM, Mansito TB (1989) Purification and peptidase activity of a bacteriolytic extracellular enzyme from Pseudomonas aeruginosa. Res Microbiol 140:125\u2013137","journal-title":"Res Microbiol"},{"key":"4484_CR21","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.copbio.2010.10.012","volume":"22","author":"L Callewaert","year":"2011","unstructured":"Callewaert L, Walmagh M, Michiels CW, Lavigne R (2011) Food applications of bacterial cell wall hydrolases. Curr Opin Biotechnol 22:164\u2013171","journal-title":"Curr Opin Biotechnol"},{"key":"4484_CR22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0723-2020(96)80004-X","volume":"19","author":"C Cavadini","year":"1996","unstructured":"Cavadini C, Hertel C, Hammes WP (1996) Stable expression of the lysostaphin gene meat lactobacilli by introducing deletions within the prosequence. Syst Appl Microbiol 19:21\u201327","journal-title":"Syst Appl Microbiol"},{"key":"4484_CR23","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4315\/0362-028X-61.4.419","volume":"61","author":"C Cavadini","year":"1998","unstructured":"Cavadini C, Hertel C, Hammes WP (1998) Application of lysostaphin-producing lactobacilli to control staphylococcal food poisoning in meat products. J Food Prot 61:419\u2013424","journal-title":"J Food Prot"},{"key":"4484_CR24","first-page":"707","volume":"48","author":"CDC","year":"1999","unstructured":"CDC (1999) Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus\u2014Minnesota and North Dakota, 1997\u20131999. MMWR Morb Mortal Wkly Rep 48:707\u2013710","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"4484_CR25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/bmj.2.5296.51-b","volume":"2","author":"ET Cetin","year":"1962","unstructured":"Cetin ET, Ang O (1962) Staphylococci resistant to methicillin (celbenin) (letter). Br Med J 2:51\u201352","journal-title":"Br Med J"},{"key":"4484_CR26","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/nrmicro2200","volume":"7","author":"HF Chambers","year":"2009","unstructured":"Chambers HF, DeLeo FR (2009) Waves of resistance: Staphylococcus aureus in the antibiotic. Nat Rev Microbiol 7:629\u2013641","journal-title":"Nat Rev Microbiol"},{"key":"4484_CR27","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1139\/m92-014","volume":"38","author":"AJ Clarke","year":"1991","unstructured":"Clarke AJ, Dupont C (1991) O-acetylated peptidoglycan: its occurrence, pathobiological significance, and biosynthesis. Can J Microbiol 38:85\u201391","journal-title":"Can J Microbiol"},{"key":"4484_CR28","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1128\/AAC.42.6.1355","volume":"42","author":"MW Climo","year":"1998","unstructured":"Climo MW, Patron RL, Goldstein BP, Archer GL (1998) Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis. Antimicrob Agents Chemother 42:1355\u20131360","journal-title":"Antimicrob Agents Chemother"},{"key":"4484_CR29","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.284.5418.1318","volume":"284","author":"JW Costerton","year":"1999","unstructured":"Costerton JW, Stewart PS, Greenberg EP (1999) Bacterial biofilms: a common cause of persistent infections. Science 284:1318\u20131322","journal-title":"Science"},{"key":"4484_CR30","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/10717544.2010.509360","volume":"17","author":"F Cui","year":"2010","unstructured":"Cui F, Li G, Huang J, Zhang J, Lu M, Lu W, Huang Q (2010) Extension of nasal anti-Staphylococcus aureus efficacy of lysostaphin by its incorporation into a chitosan-o\/w cream. Drug Deliv 17:617\u2013623","journal-title":"Drug Deliv"},{"key":"4484_CR31","first-page":"1432","volume":"41","author":"JJ Dajcs","year":"2000","unstructured":"Dajcs JJ, Hume EBH, Moreau JM, Caballero AR, Cannon BM, O\u2019Callaghan RJ (2000) Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit. Investig Ophthalmol Vis Sci 41:1432\u20131437","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"12","key":"4484_CR32","first-page":"3712","volume":"43","author":"JJ Dajcs","year":"2002","unstructured":"Dajcs JJ, Thibodeaux BA, Girgis DO, Shaffer MD, Delvisco SM, O\u2019Callaghan RJ (2002) Immunity to lysostaphin and its therapeutic value for ocular MRSA infections in the rabbit. Investig Ophthalmol Vis Sci 43(12):3712\u20133716","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"4484_CR33","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0165-2427(92)90017-K","volume":"31","author":"MJ Daley","year":"1992","unstructured":"Daley MJ, Oldham ER (1992) Lysostaphin: immunogenicity of locally administered recombinant protein used in mastitis therapy. Vet Immunol Immunopathol 31:301\u2013312","journal-title":"Vet Immunol Immunopathol"},{"key":"4484_CR34","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1128\/AAC.01625-09","volume":"54","author":"A Daniel","year":"2010","unstructured":"Daniel A, Euler C, Collin M, Chahales P, Gorelick KJ, Fischetti VA (2010) Synergism between a novel chimeric lysine and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 54:1603\u20131612","journal-title":"Antimicrob Agents Chemother"},{"key":"4484_CR35","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1128\/jb.175.9.2779-2782.1993","volume":"175","author":"BL Jonge de","year":"1993","unstructured":"de Jonge BL, Sidow T, Chang YS, Labischinski H, Berger-Bachi B, Gage DA, Tomasz A (1993) Altered muropeptide composition in Staphylococcus aureus strains with an inactivated femA locus. J Bacteriol 175:2779\u20132782","journal-title":"J Bacteriol"},{"key":"4484_CR36","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1128\/AEM.61.4.1475-1479.1995","volume":"61","author":"HP DeHart","year":"1995","unstructured":"DeHart HP, Heath HE, Heath LS, LeBlanc PA, Sloan GL (1995) The lysostaphin endopeptidase gene (epr) specifies modification of peptidoglycan cross bridges in Staphylococcus simulans and Staphylococcus aureus. Appl Environ Microbiol 61:1475\u20131479","journal-title":"Appl Environ Microbiol"},{"key":"4484_CR37","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1007\/s10096-011-1188-z","volume":"30","author":"AP Desbois","year":"2011","unstructured":"Desbois AP, Coote PJ (2011) Bactericidal synergy of lysostaphin in combination with antimicrobial peptides. Eur J Clin Microbiol Infect Dis 30:1015\u20131021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"4484_CR38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.1574-6968.2006.00483.x","volume":"265","author":"DM Donovan","year":"2006","unstructured":"Donovan DM, Lardeo M, Foster-Frey J (2006) Lysis of staphylococcal mastitis pathogens by bacteriophage phi11 endolysin. FEMS Microbiol Lett 265:133\u2013139","journal-title":"FEMS Microbiol Lett"},{"key":"4484_CR39","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1128\/JB.182.9.2635-2638.2000","volume":"182","author":"K Ehlert","year":"2000","unstructured":"Ehlert K, Tschierske M, Mori C, Schr\u00f6der W, Berger-B\u00e4chi B (2000) Site-specific serine incorporation by Lif and Epr into positions 3 and 5 of the staphylococcal peptidoglycan interpeptide bridge. J Bacteriol 182:2635\u20132638","journal-title":"J Bacteriol"},{"key":"4484_CR40","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4161\/bbug.1.1.9818","volume":"1","author":"M Fenton","year":"2010","unstructured":"Fenton M, Ross P, McAuliffe O, O\u2019Mahony J, Coffey A (2010a) Recombinant bacteriophage lysins as antibacterials. Bioeng Bugs 1:9\u201316","journal-title":"Bioeng Bugs"},{"key":"4484_CR41","doi-asserted-by":"crossref","first-page":"404","DOI":"10.4161\/bbug.1.6.13422","volume":"1","author":"M Fenton","year":"2010","unstructured":"Fenton M, Casey PG, Hill C, Gahan CG, Ross RP, McAuliffe O, O\u2019Mahony J, Maher F, Coffey A (2010b) The truncated phage lysin CHAP(k) eliminates Staphylococcus aureus in the nares of mice. Bioeng Bugs 1:404\u2013407","journal-title":"Bioeng Bugs"},{"key":"4484_CR42","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/j.1365-2672.2011.05119.x","volume":"111","author":"M Fenton","year":"2011","unstructured":"Fenton M, Ross RP, McAuliffe O, O\u2019Mahony J, Coffey A (2011) Characterization of the staphylococcal bacteriophage lysin CHAP(K). J Appl Microbiol 111:1025\u20131035","journal-title":"J Appl Microbiol"},{"key":"4484_CR43","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.biochi.2010.01.026","volume":"92","author":"LY Filatova","year":"2010","unstructured":"Filatova LY, Becker SC, Donovan DM, Gladilin AK, Klyachko NL (2010) LysK, the enzyme lysing Staphylococcus aureus cells: specific kinetic features and approaches towards stabilization. Biochimie 92:507\u2013513","journal-title":"Biochimie"},{"key":"4484_CR44","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jmb.2005.09.082","volume":"354","author":"M Firczuk","year":"2005","unstructured":"Firczuk M, Mucha A, Bochtler M (2005) Crystal structures of active LytM. J Mol Biol 354:578\u2013590","journal-title":"J Mol Biol"},{"key":"4484_CR45","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.mib.2008.09.012","volume":"11","author":"VA Fischetti","year":"2008","unstructured":"Fischetti VA (2008) Bacteriophage lysins as effective antibacterials. Curr Opin Microbiol 11:393\u2013400","journal-title":"Curr Opin Microbiol"},{"key":"4484_CR46","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1472-765X.1992.tb00651.x","volume":"14","author":"W Gaier","year":"1992","unstructured":"Gaier W, Vogel RF, Hammes WP (1992) Cloning and expression of the lysostaphin gene in Bacillus subtilis and Lactobacillus casei. Lett Appl Microbiol 14:72\u201376","journal-title":"Lett Appl Microbiol"},{"key":"4484_CR47","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.3168\/jds.2008-1744","volume":"92","author":"P Garc\u00eda","year":"2009","unstructured":"Garc\u00eda P, Madera C, Mart\u00ednez B, Rodr\u00edguez A, Evaristo Su\u00e1rez J (2009) Prevalence of bacteriophages infecting Staphylococcus aureus in dairy samples and their potential as biocontrol agents. J Dairy Sci 92:3019\u20133026","journal-title":"J Dairy Sci"},{"key":"4484_CR48","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ijfoodmicro.2010.04.029","volume":"141","author":"P Garc\u00eda","year":"2010","unstructured":"Garc\u00eda P, Mart\u00ednez B, Rodr\u00edguez L, Rodr\u00edguez A (2010) Synergy between the phage endolysin LysH5 and nisin to kill S. aureus in pasteurized milk. Int J Food Microbiol 141:151\u2013155","journal-title":"Int J Food Microbiol"},{"key":"4484_CR49","doi-asserted-by":"crossref","first-page":"6286","DOI":"10.1128\/JB.00457-06","volume":"188","author":"A Grundling","year":"2006","unstructured":"Grundling A, Missiakas DM, Schneewind O (2006) Staphylococcus aureus mutants with increased lysostaphin resistance. J Bacteriol 188:6286\u20136297","journal-title":"J Bacteriol"},{"key":"4484_CR50","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1128\/JCM.00580-11","volume":"49","author":"J Gu","year":"2011","unstructured":"Gu J, Xu W, Lei L, Huang J, Feng X, Sun C, Du C, Zuo J, Li Y, Du T, Li L, Han W (2011a) LysGH15, a novel bacteriophage lysin, protects a murine bacteremia model efficiently against lethal methicillin-resistant Staphylococcus aureus infection. J Clin Microbiol 49:11\u201317","journal-title":"J Clin Microbiol"},{"key":"4484_CR51","doi-asserted-by":"crossref","first-page":"96","DOI":"10.4161\/bbug.2.2.14883","volume":"2","author":"J Gu","year":"2011","unstructured":"Gu J, Zuo J, Lei L, Zhao H, Sun C, Feng X, Du C, Li X, Yang Y, Han W (2011b) LysGH15 reduces the inflammation caused by lethal methicillin-resistant Staphylococcus aureus infection in mice. Bioeng Bugs 2:96\u201399","journal-title":"Bioeng Bugs"},{"key":"4484_CR52","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00284-010-9699-x","volume":"62","author":"R Gupta","year":"2011","unstructured":"Gupta R, Prasad Y (2011a) Efficacy of polyvalent bacteriophage P-27\/HP to control multidrug resistant Staphylococcus aureus associated with human infections. Curr Microbiol 62:255\u2013260","journal-title":"Curr Microbiol"},{"key":"4484_CR53","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00284-011-9939-8","volume":"63","author":"R Gupta","year":"2011","unstructured":"Gupta R, Prasad Y (2011b) P-27\/HP endolysin as antibacterial agent for antibiotic resistant Staphylococcus aureus of human infections. Curr Microbiol 63:39\u201345","journal-title":"Curr Microbiol"},{"key":"4484_CR54","doi-asserted-by":"crossref","first-page":"6608","DOI":"10.1128\/jb.178.22.6608-6617.1996","volume":"178","author":"JK Gustin","year":"1996","unstructured":"Gustin JK, Kessler E, Ohman DE (1996) A substitution at His-120 in the LasA protease of Pseudomonas aeruginosa blocks enzymatic activity without affecting propeptide processing or extracellular secretion. J Bacteriol 178:6608\u20136617","journal-title":"J Bacteriol"},{"key":"4484_CR55","first-page":"110","volume":"7","author":"RI Harris","year":"1967","unstructured":"Harris RI, Nunnery AW, Riley HD (1967) Effects of lysostaphin on staphylococcal carriage in infants and children. Antimicrob Agents Chemother 7:110\u2013112","journal-title":"Antimicrob Agents Chemother"},{"key":"4484_CR56","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1046\/j.1365-2958.1997.4101774.x","volume":"24","author":"C Heilmann","year":"1997","unstructured":"Heilmann C, Hussain M, Peters G, G\u00f6tz F (1997) Evidence for autolysin-mediated primary attachment of Staphylococcus epidermidis to a polystyrene surface. Mol Microbiol 24:1013\u20131024","journal-title":"Mol Microbiol"},{"key":"4484_CR57","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/BF00331163","volume":"209","author":"P Heinrich","year":"1987","unstructured":"Heinrich P, Rosenstein R, Bohmer M, Sonner P, Gotz F (1987) The molecular organization of the lysostaphin gene and its sequences repeated in tandem. Mol Gen Genet 209:563\u2013569","journal-title":"Mol Gen Genet"},{"key":"4484_CR58","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/jac\/40.1.135","volume":"40","author":"K Hiramatsu","year":"1997","unstructured":"Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC (1997) Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 40:135\u2013136","journal-title":"J Antimicrob Chemother"},{"key":"4484_CR59","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1128\/AEM.01831-08","volume":"75","author":"M Horgan","year":"2009","unstructured":"Horgan M, O\u2019Flynn G, Garry J, Cooney J, Coffey A, Fitzgerald GF, Ross RP, McAuliffe O (2009) Phage lysin LysK can be truncated to its CHAP domain and retain lytic activity against live antibiotic-resistant staphylococci. Appl Environ Microbiol 75:872\u2013874","journal-title":"Appl Environ Microbiol"},{"key":"4484_CR60","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1128\/CMR.00042-09","volume":"23","author":"BP Howden","year":"2010","unstructured":"Howden BP, Davies JK, Johnson PD, Stinear TP, Grayson ML (2010) Reduced vancomycin susceptibility in Staphylococcus aureus, including vancomycin-intermediate and heterogeneous vancomycin-intermediate strains: resistance mechanisms, laboratory detection, and clinical implications. Clin Microbiol Rev 23:99\u2013139","journal-title":"Clin Microbiol Rev"},{"key":"4484_CR61","doi-asserted-by":"crossref","first-page":"4416","DOI":"10.1128\/AAC.00217-11","volume":"55","author":"EA Idelevich","year":"2011","unstructured":"Idelevich EA, von Eiff C, Friedrich AW, Iannelli D, Xia G, Peters G, Peschel A, Wanninger I, Becker K (2011) In vitro activity against Staphylococcus aureus of a novel antimicrobial agent, PRF-119, a recombinant chimeric bacteriophage endolysin. Antimicrob Agents Chemother 55:4416\u20134419","journal-title":"Antimicrob Agents Chemother"},{"key":"4484_CR62","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1432-1033.1973.tb03061.x","volume":"38","author":"O Iversen","year":"1973","unstructured":"Iversen O, Grov A (1973) Studies on lysostaphin. Separation and characterization of three enzymes. Eur J Biochem 38:293\u2013300","journal-title":"Eur J Biochem"},{"key":"4484_CR63","first-page":"115","volume":"1","author":"A Jakubczak","year":"2010","unstructured":"Jakubczak A, Szweda P, Kur J, Kleczkowski M, Franowska A (2010) Possibilities of application of recombined lysostaphin as an alternative agent in the therapy of Staphylococcus aureus mastitis. Adv Agric Sci 1:115\u2013120","journal-title":"Adv Agric Sci"},{"key":"4484_CR64","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S0140-6736(63)91687-8","volume":"1","author":"MP Jevons","year":"1963","unstructured":"Jevons MP, Coe AW, Parker MT (1963) Methicillin resistance in staphylococci. Lancet 1:904\u2013907","journal-title":"Lancet"},{"key":"4484_CR65","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1128\/AAC.01097-10","volume":"55","author":"SY Jun","year":"2011","unstructured":"Jun SY, Jung GM, Son JS, Yoon SJ, Choi YJ, Kang SH (2011) Comparison of the antibacterial properties of phage endolysins SAL-1 and LysK. Antimicrob Agent Chemother 55:1764\u20131767","journal-title":"Antimicrob Agent Chemother"},{"key":"4484_CR66","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/83540","volume":"19","author":"DE Kerr","year":"2001","unstructured":"Kerr DE, Plaut K, Bramley AJ, Williamson CM, Lax AJ, Moore K, Wells KD, Wall RJ (2001) Lysostaphin expression in mammary glands confers protection against staphylococcal infection in transgenic mice. Nat Biotechnol 19:66\u201370","journal-title":"Nat Biotechnol"},{"key":"4484_CR67","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/B978-0-12-079611-3.50313-X","volume-title":"The handbook of proteolytic enzymes, vol. 1","author":"E Kessler","year":"2004","unstructured":"Kessler E, Ohman DE (2004) Staphylolysin (LasA endopeptidase). In: Barrett A, Rawlings N, Woessner J (eds) The handbook of proteolytic enzymes, vol. 1, 2nd edn. Elsevier Academic, Amsterdam, pp 1001\u20131003","edition":"2"},{"key":"4484_CR68","doi-asserted-by":"crossref","first-page":"7503","DOI":"10.1016\/S0021-9258(18)53203-8","volume":"268","author":"E Kessler","year":"1993","unstructured":"Kessler E, Safrin M, Olson JC, Ohman DE (1993) Secreted LasA of Pseudomonas aeruginosa is a staphylolytic protease. J Biol Chem 268:7503\u20137508","journal-title":"J Biol Chem"},{"key":"4484_CR69","doi-asserted-by":"crossref","first-page":"30225","DOI":"10.1074\/jbc.273.46.30225","volume":"273","author":"E Kessler","year":"1998","unstructured":"Kessler E, Safrin M, Gustin JK, Ohman DE (1998) Elastase and the LasA protease of Pseudomonas aeruginosa are secreted with their propeptides. J Biol Chem 273:30225\u201330231","journal-title":"J Biol Chem"},{"key":"4484_CR70","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ab.2004.02.008","volume":"328","author":"E Kessler","year":"2004","unstructured":"Kessler E, Safrin M, Blumberg S, Ohman DE (2004) A continuous spectrophotometric assay for Pseudomonas aeruginosa LasA protease (staphylolysin) using a two-stage enzymatic reaction. Anal Biochem 328:225\u2013232","journal-title":"Anal Biochem"},{"key":"4484_CR71","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.mib.2011.10.012","volume":"15","author":"HK Kim","year":"2011","unstructured":"Kim HK, Thammavon V, Schneewind O, Missiakas D (2011) Recurrent infections and immune evasion strategies of Staphylococcus aureus. Curr Opin Microbiol 15:92\u201399","journal-title":"Curr Opin Microbiol"},{"key":"4484_CR72","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1128\/AAC.46.6.2017-2020.2002","volume":"46","author":"N Kiri","year":"2002","unstructured":"Kiri N, Archer G, Climo MW (2002) Combination of lysostaphin with beta-lactams are synergistic against oxacillin resistant Staphylococcus epidermidis. Antimicrob Agents Chemother 46:2017\u20132020","journal-title":"Antimicrob Agents Chemother"},{"key":"4484_CR73","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.3201\/eid1312.070629","volume":"13","author":"E Klein","year":"2007","unstructured":"Klein E, Smith DL, Laxminarayan R (2007) Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999\u20132005. Emerg Infect Dis 13:1840\u20131846","journal-title":"Emerg Infect Dis"},{"key":"4484_CR74","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1128\/AAC.47.5.1589-1597.2003","volume":"47","author":"JF Kokai-Kun","year":"2003","unstructured":"Kokai-Kun JF, Walsh SM, Canturiya T, Mond JJ (2003) Lysostaphin cream eradicates Staphylococcus aureus nasal colonization in a cotton rat model. Antimicrob Agents Chemother 47:1589\u20131597","journal-title":"Antimicrob Agents Chemother"},{"key":"4484_CR75","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1093\/jac\/dkp145","volume":"64","author":"JF Kokai-Kun","year":"2009","unstructured":"Kokai-Kun JF, Chanturiya T, Mond JJ (2009) Lysostaphin eradicates established Staphylococcus aureus biofilms in jugular vein catheterized mice. J Antimicrob Chemother 64:94\u2013100","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"4484_CR76","doi-asserted-by":"crossref","first-page":"171","DOI":"10.18388\/abp.2012_2136","volume":"59","author":"J Kurlenda","year":"2012","unstructured":"Kurlenda J, Grinholc M (2012) Alternative therapies in Staphylococcus aureus diseases. Acta Biochim Pol 59(2):171\u2013184","journal-title":"Acta Biochim Pol"},{"key":"4484_CR77","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00705-011-1160-3","volume":"157","author":"M Kwiatek","year":"2012","unstructured":"Kwiatek M, Parasion S, Mizak L, Gryko R, Bartoszcze M, Kocik J (2012) Characterization of a bacteriophage, isolated from a cow with mastitis, that is lytic against Staphylococcus aureus strains. Arch Virol 157:225\u2013234","journal-title":"Arch Virol"},{"key":"4484_CR78","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00109-009-0572-y","volume":"88","author":"A Laarman","year":"2010","unstructured":"Laarman A, Milder F, von Strijp J, Rooijakkers S (2010) Complement inhibition by Gram-positive pathogens: molecular mechanisms and therapeutic implications. J Mol Med (Berl) 88:115\u2013120","journal-title":"J Mol Med (Berl)"},{"key":"4484_CR79","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/nrmicro1824","volume":"6","author":"JD Lambris","year":"2008","unstructured":"Lambris JD, Ricklin D, Geisbrecht BV (2008) Complement evasion by human pathogens. Nat Rev Microbiol 6:132\u2013142","journal-title":"Nat Rev Microbiol"},{"key":"4484_CR80","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1615\/CritRevImmunol.v30.i2.40","volume":"30","author":"R Langley","year":"2010","unstructured":"Langley R, Patel D, Jackson N, Clow F, Fraser JD (2010) Staphylococcal superantigen super-domains in immune evasion. Crit Rev Immunol 30:149\u2013165","journal-title":"Crit Rev Immunol"},{"key":"4484_CR81","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.diagmicrobio.2006.09.007","volume":"57","author":"KL LaPlante","year":"2007","unstructured":"LaPlante KL (2007) In vitro activity of lysostaphin, mupirocin, and tea tree oil against clinical methicillin-resistant Staphylococcus aureus. Diagn Microbiol Infect Dis 57:413\u2013418","journal-title":"Diagn Microbiol Infect Dis"},{"key":"4484_CR82","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1017\/S0950268809991567","volume":"138","author":"A Loeffler","year":"2010","unstructured":"Loeffler A, Lloyd DH (2010) Companion animals: a reservoir for methicillin-resistant Staphylococcus aureus in the community? Epidemiol Infect 138:606\u2013625","journal-title":"Epidemiol Infect"},{"key":"4484_CR83","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.mib.2005.06.002","volume":"8","author":"MJ Loessner","year":"2005","unstructured":"Loessner MJ (2005) Bacteriophage endolysins\u2014current state of research and applications. Curr Opin Microbiol 8:480\u2013487","journal-title":"Curr Opin Microbiol"},{"key":"4484_CR84","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1172\/JCI200318535","volume":"111","author":"FD Lowy","year":"2003","unstructured":"Lowy FD (2003) Antimicrobial resistance: the example of Staphylococcus aureus. J Clin Invest 111:1265\u20131273","journal-title":"J Clin Invest"},{"key":"4484_CR85","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1080\/02713680500536753","volume":"31","author":"CC McCormick","year":"2006","unstructured":"McCormick CC, Dajcs JJ, Reed JM, Marquart ME, O\u2019Callaghan RJ (2006) The effectiveness of lysostaphin therapy for experimental coagulase-negative Staphylococcus endophthalmitis. Curr Eye Res 31:225\u2013230","journal-title":"Curr Eye Res"},{"key":"4484_CR86","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1439-0450.2006.00962.x","volume":"53","author":"MB Melchior","year":"2006","unstructured":"Melchior MB, Fink-Gremmels J, Gaastra W (2006) Comparative assessment of the antimicrobial susceptibility of Staphylococcus aureus isolates from bovine mastitis in biofilm versus planktonic culture. J Vet Med B Infect Vet Public Health 53:326\u2013332","journal-title":"J Vet Med B Infect Vet Public Health"},{"key":"4484_CR87","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.vetmic.2007.05.019","volume":"125","author":"MB Melchior","year":"2007","unstructured":"Melchior MB, Fink-Gremmels J, Gaastra W (2007) Extended antimicrobial susceptibility assay for Staphylococcus aureus isolates from bovine mastitis growing in biofilm. Vet Microbiol 125:141\u2013149","journal-title":"Vet Microbiol"},{"key":"4484_CR88","doi-asserted-by":"crossref","first-page":"9557","DOI":"10.1016\/j.biomaterials.2011.08.080","volume":"32","author":"J Miao","year":"2011","unstructured":"Miao J, Pangule RC, Paskaleva EE, Hwang EE, Kane RS, Linhardt RJ, Dordick JS (2011) Lysostaphin-functionalized cellulose fibers with antistaphylococcal activity for wound healing applications. Biomaterials 32:9557\u20139567","journal-title":"Biomaterials"},{"key":"4484_CR89","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1475-2859-4-15","volume":"4","author":"I Mierau","year":"2005","unstructured":"Mierau I, Leij P, Van Swam I, Blommestein B, Floris E, Mond J, Smidt EJ (2005a) Industrial-scale production and purification of a heterologous protein in Lactococcus lactis using the nisin-controlled gene expression system NICE: the case of lysostaphin. Microb Cell Fact 4:15","journal-title":"Microb Cell Fact"},{"key":"4484_CR90","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1475-2859-4-16","volume":"4","author":"I Mierau","year":"2005","unstructured":"Mierau I, Olieman K, Monfd J, Smidt EJ (2005b) Optimization of the Lactococcus lactis nisin-controlled gene expression system NICE for industrial applications. Microb Cell Fact 4:16","journal-title":"Microb Cell Fact"},{"key":"4484_CR91","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ijfoodmicro.2008.08.010","volume":"128","author":"JM Obeso","year":"2008","unstructured":"Obeso JM, Martinez B, Rodriguez A, Garcia P (2008) Lytic activity of the recombinant staphylococcal bacteriophage phiH5 endolysin active against Staphylococcus aureus in milk. Int J Food Microbiol 128:211\u2013218","journal-title":"Int J Food Microbiol"},{"key":"4484_CR92","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jmb.2003.11.009","volume":"16","author":"SG Odintsov","year":"2004","unstructured":"Odintsov SG, Sabala I, Marcyjaniak M, Bochtler M (2004) Latent LytM at 1.3\u00a0A resolution. J Mol Biol 16:775\u2013785","journal-title":"J Mol Biol"},{"key":"4484_CR93","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1128\/JB.187.20.7161-7164.2005","volume":"187","author":"S O\u2019Flaherty","year":"2005","unstructured":"O\u2019Flaherty S, Coffey A, Meaney W, Fitzgerald GF, Ross RP (2005) The recombinant phage lysin LysK has a broad spectrum of lytic activity against clinically relevant staphylococci, including methicillin-resistant Staphylococcus aureus. J Bacteriol 187:7161\u20137164","journal-title":"J Bacteriol"},{"key":"4484_CR94","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.3168\/jds.S0022-0302(91)78612-8","volume":"74","author":"ER Oldham","year":"1991","unstructured":"Oldham ER, Daley MJ (1991) Lysostaphin: use of recombinant bactericidal enzyme as a mastitis therapeutic. J Dairy Sci 74:4175\u20134182","journal-title":"J Dairy Sci"},{"key":"4484_CR95","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1073\/pnas.92.1.285","volume":"92","author":"T Oshida","year":"1995","unstructured":"Oshida T, Sugai M, Komatsuzawa H, Hong YM, Suginaka H, Tomasz A (1995) A Staphylococcus aureus autolysin that has an N-acetylmuramoyl-l-alanine amidase domain and an endobeta-N-acetylglucosaminidase domain: cloning, sequence analysis, and characterization. Proc Natl Acad Sci U S A 92:285\u2013289","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4484_CR96","first-page":"512","volume":"42","author":"SC Pal","year":"1964","unstructured":"Pal SC, Ghosh Ray BG (1964) Methicillin-resistant staphylococci. J Indian Med Assoc 42:512\u2013517","journal-title":"J Indian Med Assoc"},{"key":"4484_CR97","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.1021\/nn100932t","volume":"4","author":"RC Pangule","year":"2010","unstructured":"Pangule RC, Brooks SJ, Dinu CZ, Bale SS, Salmon SL, Zhu G, Metzger DW, Kane RS, Dordick JS (2010) Antistaphylococcal nanocomposite films based on enzyme\u2013nanotube conjugates. ACS Nano 4:3993\u20134000","journal-title":"ACS Nano"},{"key":"4484_CR98","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/1357-2725(94)00086-Q","volume":"27","author":"PW Park","year":"1995","unstructured":"Park PW, Senior RM, Griffin GL, Broekelmann TJ, Mudd MS, Mecham RP (1995) Binding and degradation of elastin by the staphylolytic enzyme lysostaphin. Int J Biochem Cell Biol 27:139\u2013146","journal-title":"Int J Biochem Cell Biol"},{"key":"4484_CR99","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/35075100","volume":"411","author":"PW Park","year":"2001","unstructured":"Park PW, Pier GB, Hinkes MT, Bernfield M (2001) Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence. Nature 411:98\u2013102","journal-title":"Nature"},{"issue":"24","key":"4484_CR100","doi-asserted-by":"crossref","first-page":"9135","DOI":"10.1128\/JB.00847-07","volume":"189","author":"T Park","year":"2007","unstructured":"Park T, Struck DK, Dankenbring CA, Young R (2007) The pinholin of lambdoid phage 21: control of lysis by membrane depolarization. J Bacteriol 189(24):9135\u20139139","journal-title":"J Bacteriol"},{"key":"4484_CR101","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1128\/AAC.00890-10","volume":"55","author":"M Pastagia","year":"2011","unstructured":"Pastagia M, Euler C, Chahales P, Fuentes-Duculan J, Krueger JG, Fischetti VA (2011) A novel chimeric lysin shows superiority to mupirocin for skin decolonization of methicillin-resistant and -sensitive Staphylococcus aureus strains. Antimicrob Agents Chemother 55:738\u2013744","journal-title":"Antimicrob Agents Chemother"},{"key":"4484_CR102","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1128\/AAC.43.7.1754","volume":"43","author":"RL Patron","year":"1999","unstructured":"Patron RL, Climo MW, Goldstein BP, Archer GL (1999) Lysostaphin treatment of experimental aortic valve endocarditis caused by a Staphylococcus aureus isolate with reduced susceptibility to vancomycin. Antimicrob Agents Chemother 43:1754\u20131755","journal-title":"Antimicrob Agents Chemother"},{"key":"4484_CR103","doi-asserted-by":"crossref","first-page":"4580","DOI":"10.1128\/AAC.00346-09","volume":"53","author":"B Perichon","year":"2009","unstructured":"Perichon B, Courvalin P (2009) VanA-type vancomycin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 53:4580\u20134587","journal-title":"Antimicrob Agents Chemother"},{"key":"4484_CR104","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0732-8893(93)90034-5","volume":"17","author":"J Polak","year":"1993","unstructured":"Polak J, Della Latta P, Blackburn P (1993) In vitro activity of recombinant lysostaphin\u2013antibiotic combinations toward methicillin-resistant Staphylococcus aureus. Diagn Microbiol Infect Dis 17:265\u2013270","journal-title":"Diagn Microbiol Infect Dis"},{"key":"4484_CR105","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1128\/AEM.22.3.446-450.1971","volume":"22","author":"KE Quickel","year":"1971","unstructured":"Quickel KE, Selden S, Caldwell JR, Nora NF, Scheffner W (1971) Efficacy and safety of topical lysostaphin treatment of persistent nasal carriage of Staphylococcus aureus. Appl Microbiol 22:446\u2013450","journal-title":"Appl Microbiol"},{"key":"4484_CR106","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1128\/jb.179.11.3625-3631.1997","volume":"179","author":"L Ramadurai","year":"1997","unstructured":"Ramadurai L, Jayaswal RK (1997) Molecular cloning, sequencing, and expression of lytM, a unique autolytic gene of Staphylococcus aureus. J Bacteriol 179:3625\u20133631","journal-title":"J Bacteriol"},{"key":"4484_CR107","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1099\/13500872-145-4-801","volume":"145","author":"L Ramadurai","year":"1999","unstructured":"Ramadurai L, Lockwood KJ, Nadakavukaren MJ, Jayaswal RK (1999) Characterization of a chromosomally encoded glycylglycine endopeptidase of Staphylococcus aureus. Microbiology 145:801\u2013808","journal-title":"Microbiology"},{"key":"4484_CR108","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1086\/521305","volume":"196","author":"M Rashel","year":"2007","unstructured":"Rashel M, Uchiyama J, Ujihara T, Uehara Y, Kuramoto S, Sugihara S (2007) Efficient elimination of multidrug-resistant Staphylococcus aureus by cloned lysin derived from bacteriophage \u03a6MR11. J Infect Dis 196:1237\u20131247","journal-title":"J Infect Dis"},{"key":"4484_CR109","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1128\/JB.137.3.1158-1164.1979","volume":"137","author":"JM Robinson","year":"1979","unstructured":"Robinson JM, Hardman JK, Sloan GL (1979) Relationship between lysostaphin endopeptidase production and cell wall composition in Staphylococcus staphylolyticus. J Bacteriol 137:1158\u20131164","journal-title":"J Bacteriol"},{"key":"4484_CR110","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1471-2180-11-138","volume":"11","author":"L Rodr\u00edguez","year":"2011","unstructured":"Rodr\u00edguez L, Mart\u00ednez B, Zhou Y, Rodr\u00edguez A, Donovan DM, Garc\u00eda P (2011) Lytic activity of the virion-associated peptidoglycan hydrolase HydH5 of Staphylococcus aureus bacteriophage vB_SauS-phiIPLA88. BMC Microbiol 11:138\u2013148","journal-title":"BMC Microbiol"},{"key":"4484_CR111","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1128\/AEM.00018-12","volume":"78","author":"L Rodriguez-Rubio","year":"2012","unstructured":"Rodriguez-Rubio L, Gutierrez D, Mart\u00ednez B, Rodriguez A, Garcia P (2012) Lytic activity of LysH5 endolysin secreted by Lactococcus lactis using the secretion signal sequence of bacteriocin Lcn972. Appl Environ Microbiol 78:3469\u20133472","journal-title":"Appl Environ Microbiol"},{"key":"4484_CR112","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1471-2180-12-97","volume":"12","author":"I Sabala","year":"2012","unstructured":"Sabala I, Jonsson IM, Tarkowski A, Bochtler M (2012) Anti-staphylococcal activities of lysostaphin and LytM catalytic domain. BMC Microbiol 12:97. doi: 10.1186\/1471-2180-12-97","journal-title":"BMC Microbiol"},{"key":"4484_CR113","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1099\/jmm.0.47144-0","volume":"57","author":"B Saha","year":"2008","unstructured":"Saha B, Singh AK, Ghosh A, Bal M (2008) Identification and characterization of a vancomycin-resistant Staphylococcus aureus isolated from Kolkata (South Asia). J Med Microbiol 57:72\u201379","journal-title":"J Med Microbiol"},{"key":"4484_CR114","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1128\/AEM.01616-06","volume":"73","author":"P Sass","year":"2007","unstructured":"Sass P, Bierbaum G (2007) Lytic activity of recombinant bacteriophage phi11 and phi12 endolysins on whole cells and biofilms of Staphylococcus aureus. Appl Environ Microbiol 73:347\u2013352","journal-title":"Appl Environ Microbiol"},{"key":"4484_CR115","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1128\/jb.170.6.2784-2789.1988","volume":"170","author":"PA Schad","year":"1988","unstructured":"Schad PA, Iglewski BH (1988) Nucleotide sequence and expression in Escherichia coli of the Pseudomonas aeruginosa lasA gene. J Bacteriol 170:2784\u20132789","journal-title":"J Bacteriol"},{"key":"4484_CR116","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1073\/pnas.51.3.414","volume":"51","author":"CA Schindler","year":"1964","unstructured":"Schindler CA, Schuhardt VT (1964) Lysostaphin: a new bacteriolytic agent for the Staphylococcus. Proc Natl Acad Sci U S A 51:414\u2013421","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4484_CR117","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0304-4165(65)90088-7","volume":"97","author":"CA Schindler","year":"1965","unstructured":"Schindler CA, Schuhardt VT (1965) Purification and properties of lysostaphin\u2014a lytic agent for Staphylococcus aureus. Biochim Biophys Acta 97:242\u2013250","journal-title":"Biochim Biophys Acta"},{"key":"4484_CR118","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1128\/MMBR.36.4.407-477.1972","volume":"36","author":"KH Schleifer","year":"1972","unstructured":"Schleifer KH, Kandler O (1972) Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol Rev 36:407\u2013477","journal-title":"Bacteriol Rev"},{"key":"4484_CR119","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.pep.2005.07.025","volume":"45","author":"R Sharma","year":"2006","unstructured":"Sharma R, Sharma PR, Choudhary ML, Pande A, Khatri GS (2006) Cytoplasmic expression of mature glycylglycine endopeptidase lysostaphin with an amino terminal hexa-histidine in a soluble and catalytically active form in Escherichia coli. Protein Expr Purif 45:206\u2013215","journal-title":"Protein Expr Purif"},{"key":"4484_CR120","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0167-7306(08)60410-X","volume-title":"Bacterial cell wall, vol. 27","author":"GD Shockman","year":"1994","unstructured":"Shockman GD, Holtje JV (1994) Microbial peptidoglycan (murein) hydrolases. In: Ghuysen JM, Hackenbeck R (eds) Bacterial cell wall, vol. 27. Elsevier Science, Amsterdam, pp 131\u2013166"},{"key":"4484_CR121","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1099\/00207713-32-2-170","volume":"32","author":"GL Sloan","year":"1982","unstructured":"Sloan GL, Robinson JM, Kloos WE (1982) Identification of \u2018Staphylococcus staphylolyticus\u2019 as a biovar of Staphylococcus simulans. Int J Syst Bacteriol 32:170\u2013174","journal-title":"Int J Syst Bacteriol"},{"key":"4484_CR122","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jmb.2009.12.021","volume":"396","author":"J Spencer","year":"2010","unstructured":"Spencer J, Murphy LM, Conners R, Sessions RB, Gamblin SJ (2010) Crystal structure of the LasA virulence factor from Pseudomonas aeruginosa: substrate specificity and mechanism of M23 metallopeptidases. J Mol Biol 396:908\u2013923","journal-title":"J Mol Biol"},{"key":"4484_CR123","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1056\/NEJM197408012910507","volume":"291","author":"FR Stark","year":"1974","unstructured":"Stark FR, Thornsvard C, Flannery EP, Artestein MS (1974) Systematis lysostaphin in man: apparent antimicrobial activity in a neutropenic patient. N Engl J Med 291:1355\u20131360","journal-title":"N Engl J Med"},{"issue":"Suppl 4","key":"4484_CR124","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/j.ijid.2010.05.009","volume":"14","author":"S Stefani","year":"2010","unstructured":"Stefani S, Goglio A (2010) Methicillin-resistant Staphylococcus aureus: related infections and antibiotic resistance. Int J Infect Dis 14(Suppl 4):S19\u2013S22","journal-title":"Int J Infect Dis"},{"key":"4484_CR125","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF02491501","volume":"3","author":"M Sugai","year":"1997","unstructured":"Sugai M (1997) Peptidoglycan hydrolases of the staphylococci. J Infect Chemother 3:113\u2013127","journal-title":"J Infect Chemother"},{"key":"4484_CR126","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1128\/jb.179.4.1193-1202.1997","volume":"179","author":"M Sugai","year":"1997","unstructured":"Sugai M, Fujiwara T, Akiyama T, Ohara M, Komatsuzawa H, Inoue S, Suginaka H (1997) Purification and molecular characterization of glycylglycine endopeptidase produced by Staphylococcus capitis EPK1. J Bacteriol 179:1193\u20131202","journal-title":"J Bacteriol"},{"key":"4484_CR127","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jbiotec.2005.01.012","volume":"117","author":"P Szweda","year":"2005","unstructured":"Szweda P, Kotlowski R, Kur J (2005) New effective sources of the Staphylococcus simulans lysostaphin. J Biotechnol 117:203\u2013213","journal-title":"J Biotechnol"},{"key":"4484_CR128","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1745-4565.2007.00078.x","volume":"27","author":"P Szweda","year":"2007","unstructured":"Szweda P, Lacka I, Kotlowski R, Synowiecki J (2007) Protective effect of lysostaphin from Staphylococcus simulans against Staphylococcus aureus in milk and some other food products. J Food Safety 27:265\u2013274","journal-title":"J Food Safety"},{"key":"4484_CR129","first-page":"281","volume":"28","author":"SS Taiwo","year":"2009","unstructured":"Taiwo SS (2009) Methicillin resistance in Staphylococcus aureus: a review of the molecular epidemiology, clinical significance and laboratory detection methods. West Afr J Med 28:281\u2013290","journal-title":"West Afr J Med"},{"key":"4484_CR130","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1128\/AAC.49.7.2934-2940.2005","volume":"49","author":"M Takac","year":"2005","unstructured":"Takac M, Blasi U (2005) Phage 68 virion-associated protein 17 displays activity against clinical isolates of Staphylococcus aureus. Antimicrob Agents Chemother 49:2934\u20132940","journal-title":"Antimicrob Agents Chemother"},{"key":"4484_CR131","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1046\/j.1365-2958.1997.2911657.x","volume":"23","author":"G Thumm","year":"1997","unstructured":"Thumm G, Gotz F (1997) Studies on prolysostaphin processing and characterization of the lysostaphin immunity factor (Lif) of Staphylococcus simulans biovar staphyloticus. Mol Microbiol 23:1251\u20131265","journal-title":"Mol Microbiol"},{"key":"4484_CR132","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1128\/9781555816513.ch36","volume-title":"Gram-positive pathogens","author":"A Tomasz","year":"2006","unstructured":"Tomasz A (2006) The staphylococcal cell wall. In: Fischetti VA, Novick RP, Ferretti JJ, Portnoy DA, Rood JI (eds) Gram-positive pathogens, 2nd edn. ASM, Washington, pp 443\u2013455","edition":"2"},{"key":"4484_CR133","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0195-6701(93)90100-E","volume":"25","author":"EE Udo","year":"1993","unstructured":"Udo EE, Pearman JW, Grubb WB (1993) Genetic analysis of community isolates of methicillin-resistant Staphylococcus aureus in Western Australia. J Hosp Infect 25:97\u2013108","journal-title":"J Hosp Infect"},{"key":"4484_CR134","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1017\/S0950268809991567","volume":"138","author":"W Vanderhaeghen","year":"2010","unstructured":"Vanderhaeghen W, Hermans K, Haesebrouck F, Butaye P (2010) Methicillin-resistant Staphylococcus aureus (MRSA) in food production animals. Epidemiol Infect 138:606\u2013625","journal-title":"Epidemiol Infect"},{"key":"4484_CR135","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1046\/j.1432-1327.2001.01967.x","volume":"268","author":"S Vessillier","year":"2001","unstructured":"Vessillier S, Delolme F, Bernillon J, Saulnier J, Wallach J (2001) Hydrolysis of glycine-containing elastin pentapeptides by LasA, a metalloelastase from Pseudomonas aeruginosa. Eur J Biochem 268:1049\u20131057","journal-title":"Eur J Biochem"},{"key":"4484_CR136","first-page":"191","volume":"54","author":"E Walencka","year":"2005","unstructured":"Walencka E, Sadowska B, Rozalska S, Hryniewicz W, Rozalska B (2005) Lysostaphin as a potential therapeutic agent for staphylococcal biofilm eradication. Pol J Microbiol 54:191\u2013200","journal-title":"Pol J Microbiol"},{"key":"4484_CR137","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/BF02931580","volume":"51","author":"E Walencka","year":"2006","unstructured":"Walencka E, Sadowska B, Rozalska S, Hryniewicz W, Rozalska B (2006) Staphylococcus aureus biofilm as a target for single or repeated doses of oxacillin, vancomycin, linezolid and\/or lysostaphin. Folia Microbiol (Praha) 51:381\u2013386","journal-title":"Folia Microbiol (Praha)"},{"key":"4484_CR138","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nbt1078","volume":"23","author":"RJ Wall","year":"2005","unstructured":"Wall RJ, Powell AM, Paape MJ, Kerr DE, Bannerman DD, Pursel VG, Wells KD, Talbot N, Hawk HW (2005) Genetically enhanced cows resist intramammary Staphylococcus aureus infection. Nat Biotechnol 23:445\u2013451","journal-title":"Nat Biotechnol"},{"key":"4484_CR139","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1128\/AAC.47.2.554-558.2003","volume":"47","author":"S Walsh","year":"2003","unstructured":"Walsh S, Shah A, Mond J (2003) Improved pharmacokinetics and reduced antibody reactivity of lysostaphin conjugated to polyethylene glycol. Antimicrob Agents Chemother 47:554\u2013558","journal-title":"Antimicrob Agents Chemother"},{"key":"4484_CR140","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1146\/annurev.micro.54.1.799","volume":"45","author":"IN Wang","year":"2000","unstructured":"Wang IN, Deaton J, Young R (2000) Holins: the protein clocks of bacterial infection. Annu Rev Microbiol 45:799\u2013825","journal-title":"Annu Rev Microbiol"},{"key":"4484_CR141","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.vetmic.2009.01.039","volume":"140","author":"JS Weese","year":"2010","unstructured":"Weese JS, van Duijkeren E (2010) Methicillin-resistant Staphylococcus aureus and Staphylococcus pseudointermedius in veterinary medicine. Vet Microbiol 140:418\u2013429","journal-title":"Vet Microbiol"},{"key":"4484_CR142","first-page":"802","volume":"79","author":"M Welsch","year":"1950","unstructured":"Welsch M, Salmon J (1950) Quelques aspects de la staphylolyse. Ann Inst Pasteur 79:802\u2013813","journal-title":"Ann Inst Pasteur"},{"key":"4484_CR143","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1128\/AAC.47.11.3407-3414.2003","volume":"47","author":"JA Wu","year":"2003","unstructured":"Wu JA, Kusuma C, Mond JJ, Kokai-Kun JF (2003) Lysostaphin disrupts Staphylococcus aureus and Staphylococcus epidermidis biofilms on artificial surfaces. Antimicrob Agents Chemother 47:3407\u20133414","journal-title":"Antimicrob Agents Chemother"},{"key":"4484_CR144","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0168-6445(94)00079-4","volume":"17","author":"R Young","year":"1995","unstructured":"Young R, Blasi U (1995) Holins: form and function in bacteriophage lysis. FEMS Microbiol Rev 17:191\u2013205","journal-title":"FEMS Microbiol Rev"},{"key":"4484_CR145","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.5897\/AJB11.3426","volume":"11","author":"B Zhang","year":"2012","unstructured":"Zhang B, Shangguan T, Ma H, Huang X, Zhang Y (2012) Lysis of mastitis pathogens isolated from dairy cow milk samples by purified recombinant lysostaphin. Afr J Biotechnol 11:4649\u20134659","journal-title":"Afr J Biotechnol"},{"key":"4484_CR146","first-page":"65","volume":"21","author":"R-Q Zhou","year":"1989","unstructured":"Zhou R-Q, Chen S-G, Recsei AP (1989) Prolysostaphin-processing protease from Staphylococcus simulans purification and some properties. Acta Biochim Biophys Sin 21:65\u201371","journal-title":"Acta Biochim Biophys Sin"},{"key":"4484_CR147","first-page":"309","volume":"16","author":"WA Zygmunt","year":"1972","unstructured":"Zygmunt WA, Tawormina PA (1972) Model for a specific enzymatic approach to infectious disease. Prog Drug Res 16:309\u2013333","journal-title":"Prog Drug Res"}],"container-title":["Applied Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1007\/s00253-012-4484-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T09:32:22Z","timestamp":1643535142000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00253-012-4484-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,18]]},"references-count":147,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["4484"],"URL":"https:\/\/doi.org\/10.1007\/s00253-012-4484-3","relation":{},"ISSN":["0175-7598","1432-0614"],"issn-type":[{"value":"0175-7598","type":"print"},{"value":"1432-0614","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,18]]}}}